Psychopharmacological treatment of patients with HIV/AIDS

摘要

Knowledge of psychopharmacology is critical to the management of patients with human immunodeficiency virus (HIV) infection, due to the prevalence of premorbid psychopathology and substance use disorders (SUDs); HIV-associated neurocognitive disorders (HAND); somatic symptoms such as pain and fatigue, and neuroendocrine problems, all of which impact quality of life.